Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on September 18th, 2023%
A crowdsourced competition offered by NIH is seeking new technologies to monitor the health and detect early problems with new babies and their mothers, at the point of care or in the home. . . . → Read More: Challenge Seeks Point-of-Care, Home Maternal Health Technologies
By Alan, on September 15th, 2023%
I.T. systems company Fujitsu Ltd. is providing artificial intelligence model generation and fairness assessment software as open-source projects hosted by the Linux Foundation. . . . → Read More: Fujitsu, Linux Foundation Partner on Open-Source A.I.
By Alan, on September 14th, 2023%
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies
By Alan, on September 13th, 2023%
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment
By Alan, on September 12th, 2023%
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M
By Alan, on September 11th, 2023%
Results of a clinical trial show one radiologist using software with artificial intelligence can detect more breast cancer cases in mammograms than current reviews by two radiologists. . . . → Read More: A.I. Mammogram Screening Shown to Improve Cancer Detection
By Alan, on September 8th, 2023%
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies. . . . → Read More: Neurons from Stem Cells Produced for Overdose Therapy Tests
By Alan, on September 6th, 2023%
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company
By Alan, on September 5th, 2023%
Results of a clinical trial show a vaccine delivered as a nasal spray protects healthy people against infection from the bacteria causing whooping cough infections. . . . → Read More: Trial Shows Nasal Vaccine Reduces Whooping Cough Bacteria
By Alan, on August 25th, 2023%
A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders. . . . → Read More: Trial Begins for Multi-Neurological Disease Therapy
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|